See also this year's filing and all EDGAR filings for this company.
PDF Report 0001367920_2017_Concert_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001367920, Concert Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 97,729,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,199,000 |
| 3 | remainder_Assets | 467,000 |
| 4 | LiabilitiesCurrent | 5,570,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 9,231,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,358,000 |
| 9 | ResearchAndDevelopmentExpense | 36,983,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 174,000 |
| 12 | remainder_NetIncome | 447,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 100,395,000 |
| 1 | Liabilities | 14,801,000 |
| 2 | Expenses | 51,341,000 |
| 3 | Revenues | 174,000 |
| 4 | StockholdersEquity | 85,594,000 |
| 5 | NetIncome | -50,720,000 |
| 6 | ComprehensiveNetIncome | -50,720,000 |
| 7 | BaseVar | 83,579,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.36 |
| 9 | EconomicCapitalRatio | 3.26 |